Search
for
Sort by
Research 151–180 of 1000+
- Progress in Relevant Growth Factors Promoting the Growth of Hair Follicle
- Licorice: A review on phytochemical insights and therapeutic potential
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Promotion of mouse ameloblast proliferation by Lgr5 mediated integrin signaling
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Trend and Co-occurrence Network of COVID-19 Symptoms From Large-Scale Social Media Data: Infoveillance Study
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- COVID-19 Severity and Androgen Receptor Polymorphism
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- The 100 most cited articles in androgenetic alopecia: A bibliometric analysis
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- A case of rapid progression of central centrifugal cicatricial alopecia after COVID-19 infection
- β-catenin Activity in the Dermal Papilla Regulates Morphogenesis and Regeneration of Hair
- COVID-19 infection is a major cause of acute telogen effluvium
- ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients
- Association of androgenetic alopecia with a more severe form of COVID-19 infection
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
- Molecular basis of hypohidrotic ectodermal dysplasia: an update
- Oral Lichen Planus
- Engineered Exosomes Co-Delivering EGF and FGF Ameliorate Androgenetic Alopecia in a Mouse Model
- WNT Signaling in Disease